U Magazine
U Magazine
UCLA Health
 
David Geffen School of Medicine
 
ISSUE VIEWING
IN THIS ISSUE
MOST POPULAR
The Cutting Edge

New Method to Study Mitochondrial DNA Diseases

  Promising New Approach to Treat Duchenne Muscular Dystrophy
  Promising New Approach to Treat Duchenne Muscular Dystrophy
 

Top: Diagram illustrates the process of transferring mitochondria between cells using the nanoblade technology. Bottom: Osteosarcoma cells and mitochondria (green), with additional mitochondria (red) transferred via the nanoblade.
Images: Courtesy of Dr. Michael Teitell

A UCLA-led team has demonstrated a new method to conduct research on mitochondrial DNA diseases — a broad group of debilitating genetic disorders that can affect the brain, heart and muscles. The new method utilizes a technology developed by UCLA researchers that opens holes in the cell membrane. The researchers say that it could pave the way for specific research on how and why these diseases occur and point to pathways to develop treatments.

Mitochondria, often referred to as the cell’s “energy powerhouse,” are small organelles that reside inside a cell’s cytoplasm but outside the nucleus. They convert food into energy and building blocks for cells in a process known as metabolism. Mutations in mitochondrial DNA, or mtDNA, can cause devastating diseases that mainly affect tissues and cells with high-energy demands. One of the best-known mtDNA diseases is Leber’s hereditary optic neuropathy, which can cause sudden and profound loss of central vision. Because mitochondria in humans are maternally inherited, mtDNA diseases can be passed from an unaffected mother to her children.

“Although specific mtDNA diseases are rare, the collective prevalence of mtDNA diseases from all types of mtDNA mutations is estimated to be 1 in 5,000 individuals,” says Michael Teitell, MD ’93, PhD ’93, director of basic and translational research in the UCLA Jonsson Comprehensive Cancer Center. He added that the “new approach for mitochondrial transfer into cells could open new possibilities for understanding how specific mtDNA mutations alter cell metabolism and potentially provide a way forward in treating specific mtDNA diseases.”

According to the researchers, mitochondria with healthy mtDNA could be delivered into cells with damaged mtDNA, which could dramatically reduce a disease’s effects — or possibly eliminate them. To begin to address these and other complex issues surrounding mtDNA alterations, UCLA researchers, led by Dr. Teitell and Pei-Yu (Eric) Chiou, PhD, professor of mechanical and aerospace engineering in the UCLA Henry Samueli School of Engineering and Applied Science, collaborated on a new precision-cutting tool.

The tool, a “photothermal nanoblade,” opens holes in the outer membrane of a cell to enable pressurized delivery of desired contents, in this case healthy mitochondria, into the cell cytoplasm. “Our photothermal nanoblade can open a micron-sized pore through a cell membrane by utilizing an ultrafast laser-induced cavitation bubble for precision cutting,” Dr. Chiou says. “This process keeps cells alive as the nanoblade tool never enters the cell. So we can achieve a very high efficiency in the delivery of large-sized, slow-diffusing cargo, such as mitochondria.”

Additionally, Drs. Chiou and Teitell are engineering an approach that incorporates the nanoblade into a high-throughput system that could deliver desired cargo, such as mitochondria, into as many as 100,000 cells per minute.

“Mitochondrial Transfer by Photothermal Nanoblade Restores Metabolite Profile in Mammalian Cells,” Cell Metabolism, May 10, 2016

 





Add a comment


Please note that we are unable to respond to medical questions. For information about health care, or if you need help in choosing a UCLA physician, please contact UCLA Physician Referral Service (PRS) at 1-800-UCLA-MD1 (1-800-825-2631) and ask to speak with a referral nurse. Thank you.